MHRA races into the lead in authorising experimental gene therapies
FIRST mRNA, then CRISPR. The Medicines and Healthcare products Regulatory Agency (MHRA), having acquired a taste for leading the world in authorising genetic therapies when it authorised the Pfizer/BioNTech mRNA genetic ‘vaccine’ in December 2020, is back to the business of enabling. On November 15 the MHRA became the first regulator in the world to […]